🇺🇸 FDA
Patent

US 10351628

Antibody fragments, compositions and uses thereof

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 10351628 (Antibody fragments, compositions and uses thereof) held by METIS PRECISION MEDICINE SB S.R.L. expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
METIS PRECISION MEDICINE SB S.R.L.
Grant date
Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K39/3955, A61K45/06, A61K48/0016